ABSTRACT: Effects of three polymers, polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and copolymer of vinyl pyrrolidone/vinyl acetate (PVP-VA), on the dissolution behaviour of the cocrystals of flufenamic acid with theophylline (FFA-TP CO) and nicotinamide (FFA-NIC CO) were investigated at multiple length scales. At the molecular level, the interactions of crystal surfaces with a polymer were analysed by observing etching pattern changes using atomic force microscopy. At the macroscopic scale, dissolution rates of particular faces of a single crystal were determined by measurement of the physical retreat velocities of the faces using optical light microscopy. In the bulk experiments, the FFA concentration in a dissolution medium in the absence or presence of a polymer was measured under both sink and non-sink conditions. It has been found that the dissolution mechanisms of FFA-TP CO are controlled by the defect sites of the crystal surface and by precipitation of the parent drug FFA as individual crystals in the bulk fluid. In contrast, the dissolution mechanisms of FFA-NIC CO are controlled by surface layer removal and by a surface precipitation mechanism, where the parent drug FFA precipitates directly onto the surface of the dissolving cocrystals. Through controlling the dissolution environment by pre-dissolving a polymer, PVP or PVP-VA, which can interact with the crystal surface to alter its dissolution properties, improved solubility and dissolution rates of FFA-TP CO and FFA-NIC CO have been demonstrated.
INTRODUCTION
Pharmaceutical cocrystals have attracted remarkable interests for enhancing solubility and dissolution rates of poorly water soluble drugs. [1] [2] [3] A highly supersaturated solution concentration, which is significantly greater than the equilibrium saturation concentration of the parent drug, can be generated due to rapid dissolution of cocrystals, which is a key requirement for improved drug oral absorption. 4 However, maintaining such a supersaturated state is challenging because of the tendency for rapid precipitation of a more stable form of the parent drug during dissolution. 5, 6 In order to maximise the potential of cocrystals, it is critical to include inhibitors in a formulation to prevent or delay the precipitation of the parent drug during dissolution. [7] [8] [9] [10] [11] [12] [13] Although polymeric crystallization inhibitors have been extensively studied in many other systems, in particular amorphous solid dispersions, 14, 15 such studies are still rare for cocrystal based formulations. In a recent study, we have found that the competition of intermolecular hydrogen bonding among drug/coformer, drug/polymer, and coformer/polymer was a key factor responsible for maintaining the supersaturation through nucleation inhibition and crystal growth modification in a supersaturated cocrystal solution with a pre-dissolved polymer. 11 Therefore, selection of a polymeric excipient in a cocrystal formulation should consider the interplay of a polymer with both the parent drug and coformer in solution. On the other hand, it has to be stressed that pre-dissolved polymeric additives in solution can not only function as an inhibitor to maintain the supersaturated state of the parent drug, but also influence the dissolution properties of solid crystals. Therefore, the performance of cocrystal based products is determined by the overall effects of an inhibitor on both cocrystal dissolution and parent drug precipitation.
The process of crystal dissolution can be considered as specific types of heterogeneous reactions between the solid and solvent, in which solvent molecules are first adsorbed onto the crystal surface. 16 Then, through interaction or reaction between the crystal and the adsorbed solvent molecules, the crystal molecules detach and diffuse away from the surface.
Using atomic force microscopy (AFM), different etching patterns can be observed during crystal dissolution, affected by the crystal interaction network and the interactions between the crystal molecules in the lattice and solvent molecules. [17] [18] [19] [20] [21] [22] When a polymer is present in solution, the polymer molecules can also be adsorbed on the surface of the dissolving crystal to form an adsorption layer, which affects solute bulk diffusion as well as surface diffusion.
There are many factors affecting adsorption of a polymer on a crystal surface, such as properties of the polymer (i.e. polymer chains and chain rigidity) and crystal structure (i.e. molecular packing) and the adsorption energy involved in the specific interactions between the polymer and crystal surface, 18, [23] [24] [25] For example, polyvinylpyrrolidone (PVP) and hydroxyporpyl methylcelluclose (HPMC) can slow down the intrinsic dissolution rate of acetaminophen crystals due to their strong interactions with the crystal surface through either van de Waals or hydrogen bonding interactions. In contrast, although the polymers poly(vinyl alcohol) (PVA) and poly(ethylene glycol) (PEG) can interact the crystal surface of acetaminophen through hydrogen bonding, they had no significant inhibitory effect on the dissolution and crystallization, because of high mobility of the functional groups. 18 As a crystal dissolves, rates of dissolution of its faces are distinctly different due to their different interactions with the dissolution medium. A polar solvent is more likely to interact with polar crystal faces where polar atoms or functional groups are exposed normal to the faces. 26 Through measurement of the physical retreat rates of individual faces of a single crystal, a crystal surface dependent dissolution rate can be obtained, which can be used to determine the relationship between crystal morphology and bulk dissolution rates. 27, 28 This knowledge of anisotropic dissolution behaviour of single crystals can highlight the factors affecting crystal dissolution, which is crucial in the design, evaluation and control of therapeutic efficacy of solid dosage forms. 29, 30 Due to the complexity arising from the multi-component nature of pharmaceutical cocrystals, it is expected that the knowledge from single component crystals needs to be rigorously validated and further extended when applied to the dissolution of cocrystals. The present work, for the first time, is aimed at understanding the dissolution mechanisms of cocrystals in solution in the absence and presence of a pre-dissolved polymer. We carried out different dissolution experiments of both single and power cocrystals to examine the dissolution properties at multiple length scales. At the molecular level, we investigated how a cocrystal surface interacted with a polymer by analysing the etching pattern changes observed by AFM. At the macroscopic scale, dissolution rates of particular faces of a single crystal were determined by measurement of the physical retreat velocities of different faces using optical light microscopy (OLM). In the bulk experiments, the concentration of a drug in a dissolution medium in the absence or presence of a polymer was measured under both sink and non-sink conditions and the dissolution rate was deduced from the evolution of this concentration. Sink condition experiments were performed to evaluate the effect of a polymer on the dissolution rate of cocrystals, and non-sink condition ones to evaluate the ability of a polymer to generate and maintain supersaturated drug solutions. Under sink conditions the change of a cocrystal dissolution rate during dissolution should be directly related to the interaction between the pre-dissolved polymer in solution with the dissolving crystal surface.
Evaluation of the supersaturating systems benefits from the use of non-sink conditions that mimic the in vivo conditions in the gastrointestinal tract. The cocrystals of flufenamic acidnicotinamide (FFA-NIC CO) and flufenamic acid-theophylline (FFA-TP CO) with three chemically diverse polymers, polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and copolymer of vinyl pyrrolidone/vinyl acetate (PVP-VA) were selected, with the aim to identify the different influences of these polymers on cocrystal dissolution. The chemical structures of the model drug, the coformers, and the monomer units of the polymers are shown in Table 1 and their detailed description can be found in our previous publication. 11 In order to eliminate the effect of viscosity, a low polymer concentration of 200 µg/mL was used in the study. At this polymer concentration the equilibrium solubility of FFA remained virtually the same as without the presence of the polymers. Because of the thermodynamically unstable nature of a cocrystal in solution, the solubility of FFA-TP CO and FFA-NIC CO was determined by their eutectic points through measuring their solubility curves. 31 The faces of FFA I (flufenamic acid form I), FFA-TP CO and FFA-NIC CO single crystals were indexed using X-ray diffraction and nanometre-scale models of their morphologies which were created using Mercury 3.9 (The Cambridge crystallographic Data
Centre, Cambridge, UK). These morphology models were also used to explain the properties of each face of a single crystal in the AFM and OLM dissolution experiments. In order to quantify the effect of a pre-dissolved polymer on the powder dissolution performance, the dissolution performance parameters (DPPs) in different non-sink condition experiments were calculated and compared. The solid residues after the solubility and powder dissolution experiments were examined by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and Fourier transform infrared spectroscopy (FTIR). were mounted on an Oxford Diffraction XCalibur diffractometer. Only a few X-ray images were collected for each crystal, which allowed determination of the unit cell parameters and the orientation matrix. The major faces could then be identified by orienting the crystals in specific crystallographic directions on the diffractometer, while observing them through the built-in camera. Models of the observed morphologies were created in Mercury 3.9 (The Cambridge crystallographic Data Centre, Cambridge, UK) by manually adjusting the list of faces and face-to-centroid distances to match those observed experimentally on the diffractometer. A summary of these results is given in Figure 2 , with the single crystal indexing data in Table S1 in the supplementary materials. Atomic Force Microscopy (AFM) Measurements. Single crystals with well-defined and visually flat faces were selected for dissolution study. In order to correlate the etching pits with the crystal structure, the axis directions were determined by comparing the observed crystal face with the indexed crystal morphology created by Mercury 3.9. A single crystal was first mounted onto an AFM sample disk using double-sided seal tape, in which the studied face was up. The prepared sample disk was then immersed in a petri dish with 20 mL of 0.01 M pH 6.8 PBS in the absence or presence of a polymer at room temperature for a period of time varying from 2 min to 10 min as shown in Table 3 . After a predetermined time interval, the disk was taken from the solution and the remaining solution on the crystal surface was removed with filter paper. Finally, the sample was air-dried for at least 0.5 h before AFM observation.
MATERIALS AND METHODS

Apparent Equilibrium
The surfaces of single crystals of FFA I, FFA-TP CO and FFA-NIC CO before and after the immersing dissolution tests [ FFA-NIC CO were performed under both sink and non-sink conditions. All crystalline materials prior to the tests were slightly ground by a mortar and pestle and sieved by a 60 mesh sieve (below 250µm) to reduce the effect of particle size on the dissolution rates. 400 
Dissolution Performance Parameter (DPP). Dissolution performance parameter (DPP),
analogous to the supersaturation parameter in our previous publication, 11 was used to evaluate the dissolution profile of cocrystal powders in the absence or presence of a predissolved polymer in comparison to a reference system. . In order to quantitatively compare the dissolution performance of two solids, DPP is defined as
Solids with a positive DPP value have an increased ability to dissolve and to be maintained in a dissolution medium, while as a negative DPP value indicates that solids have a less ability to dissolve and to be maintained in solution. 
Fourier Transform Infrared Spectroscopy (FTIR).
An ALPHA interferometer (Bruker UK Limited, Coventry, UK), equipped with a horizontal universal attenuated total reflectance (ATR) accessory, was used to measure the FTIR spectra of solid samples. For each of the samples, 30 scans were collected per spectrum with a resolution of 2 cm -1 in the spectral region of 400 to 4000 cm -1 using the OPUS software. All the spectral data were collected at an ambient temperature.
RESULTS
FFA I and FFA Cocrystals Characterization, Morphology Prediction and Face
Indices. Single cocrystals of FFA-NIC CO and FFA-TP CO were grown using the slow solvent evaporation technique described in the Materials and methods section. The identities of the crystals have been confirmed by PXRD, DSC and FTIR measurements [See Figure S1 in the supplementary materials]. Single FFA-NIC COs harvested were thin, brick-shaped and single FFA-TP COs were chunky, with sizes ranging from millimetres up to one centimetre.
The single crystals of FFA I from the received materials were plate-like with a wider size range from millimetres up to one centimetre. Representative microscopy images of these single crystals are shown in Figure 2 .
Models of the crystal morphologies were created using Mercury 3.9 based on the crystal structures of each material obtained from the Cambridge Structural Database (CSD refcodes:
FPAMCA18 for FFA I; EXAQAW for FFA-NIC CO; ZIQDUA for FFA-TP CO, detailed in Table S1 in the supplementary materials) and face indexing of representative single crystals using an X-ray diffractometer [Section 2.2, Figure 2 ].
The FFA I structure is formed with hydrogen-bonded dimers between the carboxyl groups of two FFA molecules. 32 In the FFA-NIC CO structure, hydrogen-bonded rings are formed by two FFA and two NIC molecules. These four-molecule rings are linked into infinite tubes by the amide chain motif. 33 Regarding the FFA-TP CO structure, TP molecules form a dimer via N-H···O hydrogen bonds involving the saturated N atom of the imidazole ring and one of the carbonyl groups. An O-H···N hydrogen bond involving the carboxylic acid of the FFA and unsaturated N atom of the imidazole ring of TP results in a fourcomponent supramolecular unit. 34 The identity of each powder sample was confirmed by comparison of the measured and predicted PXRD patterns shown in Figure 2 . It can be seen that the calculated PXRD patterns were in good agreement with the experimental data for all crystals. All main PXRD peaks of FFA I were predicted accurately. Some mismatched peak positions in the predicted and measured PXRD patterns of cocrystals of FFA-NIC CO and FFA-TP CO were found in Figure 2 (indicated by arrows). These differences were likely to come from the different temperatures of the measurements, i.e., room temperature for PXRD measurements and around 100 K for the single crystal data. 33, 34 At different temperatures the size of the unit cell will be (slightly) different, leading to the shifts of the PXRD peak positions.
In comparison with the observed single crystal images in Figure 2 , it can be seen that the crystal morphologies of FFA I, FFA-TP CO and FFA-NIC CO are represented accurately by the models created by the software of Mercury 3.9. Therefore each surface of a single crystal can be assigned through directly comparing the measured image with its morphology model.
Six well-defined planes of a single FFA I crystal were identified, with a pair of major faces, (100) and (-100), bounded by two pairs of the less prominent side faces (011), (0,-1,-1), (01-1) and (0-11). The (100) plane could expose either the COOH or the CF 3 groups
[ Figure 2 ]. The (0-11) face, on the other hand, exposes the COOH and CF 3 groups simultaneously, along with the aromatic rings [ Figure 2 ]. Based on this structural inspection, it is expected that subsequent (100) layers with dominant CF 3 …CF 3 contacts should have lower attachment energy than the (0-11) faces and have a slow growth rate normal to the surface, leading to a large face.
The rectangular shape of FFA-TP CO is formed with a pair of the dominant (001) and (00-1) faces, larger side faces (0-10) and (010), and smaller side faces (100) and (-100). The (001) face could again have a more hydrophobic nature, because the trifluoromethylbenzene rings of FFA are exposed almost perpendicularly out of this surface. In contrast, the crystal faces (0-10) and (100) are more hydrophilic, because they expose more hydrogen-bond donors and acceptors.
The dominant pair of FFA-NIC CO faces are (0-11) and (01-1), with less prominent faces (011) and (0-1-1) and the smallest pair of (-100) and (100). On the (100) face, both COOH groups of FFA and CONH 2 groups of NIC are exposed, resulting in a polar surface.
The (01-1) plane is less polar, carbon, fluorine and hydrogen atoms are dominating the exposed area. Table 2 ]. The molar ratio of FFA to TP at the transition point was 0.26:1, indicating that the system is incongruently saturating. The solubility of FFA-TP CO was calculated as 2.99 mmol/mL using Equation (1), which is a 2.25-fold increase compared to the solubility of FFA I alone.
The apparent concentration of FFA I as a function of NIC concentration is shown in Figure 3 (c), which is similar to a previous work. 8 The apparent solubility of FFA I increased with increasing NIC concentration up to 61.8 mM, indicating complex formation of FFA and NIC in solution. In this region, the solubility limit of the complex formed was not exceeded, therefore the solid residues were FFA I alone, confirmed by PXRD results in Figure 3 FFA-NIC CO shows complicated face dependent dissolution behaviour in Figures.
5(b9)-(b12)
. In contrast to FFA I and FFA-TP CO, the dissolution rate increased rapidly on both of faces in the presence of PVP or PVP-VA in PBS. The variation of the dissolution rate on the small (100) face was significantly higher than the big face (01-1). It was interesting to note that the pre-dissolved PEG in solution decreased the dissolution of the small face (100) and increased the dissolution of the big face (01-1), leading to close to isotropic dissolution behaviour of FFA-NIC CO faces. Furthermore, only FFA-NIC CO faces showed good linear dissolution behaviour in PBS in the presence of a polymer of PEG. Figure 8 shows the dissolution profiles of FFA I, FFA-TP CO and FFA-NIC CO in the absence and presence of a polymer under non-sink conditions. Therefore was the FFA I solubility of 373.3 µg/mL measured in this study in Table 2 . and values of each test are shown in Tables 4 and 5 . In the presence of a polymer, FFA I solids dissolved slower [ Table 4 ], in particular, the pre-dissolved PVP lead to 38% reduction of AUC in Figure 8 (e). There was no supersaturation generated from FFA I dissolution in PBS in the absence or presence of PEG, PVP or PVP-VA [ Table 5 Table 4 ]. There was no dissolution advantage observed for FFA-NIC COs in PBS alone or in the presence of pre-dissolved PEG. However, in the presence of PVP in the solution, the advantage of FFA-NIC COs in dissolution performance was apparent, with a 64% increase of AUC [ Figure 8 (e)], 50% higher peak solubility [ Table   5 ], and faster dissolution rate [ Table 4 ]. Similarly, in the presence of PVP-VA in solution, the DPP of FFA-NIC COs was increased by 60% and the maximum FFA concentration was 1.6 times of its solubility.
Powder Dissolution Under Sink and Non-Sink Conditions.
The PXRD results of the solid residues collected after the FFA I dissolution experiments were the same as for the starting materials, shown in Figure 9 
DISCUSSION
It is well known that the dissolution mechanism of the cocrystals of poorly water soluble drugs is complex, in which both dissolution of the cocrystals and the precipitation of the parent drug can occur simultaneously depending on the properties of the parent drug and coformer and the experimental conditions. 5 In this study, through rational selection of a coformer as well as the dissolution medium in the presence of a polymeric additive, we aimed to provide mechanistic insights into the intrinsic relationship among dissolution, supersaturation and precipitation for pharmaceutical cocrystals. Figure S6 ] observed by AFM. Consequently this resulted in reduction of the dissolution rate of FFA-NIC CO. Therefore, the dissolution profile of FFA-NIC CO was similar to FFA I, which was observed in the bulk powder dissolution in Figure   8 (a). It has been reported that FFA has up to nine different crystal forms, among which FFA I (white colour) and FFA III (yellow colour) are the most commonly encountered. 35 Below a temperature of 42°C FFA III is the most stable form and has a lower solubility than its metastable form of FFA I, although the solubility difference between the two forms is very small with less than 1 µg/mL. 37 Precipitation of the solid FFA III during dissolution under non-sink conditions shown in Figure 9 (c) demonstrated that the supersaturation was first generated by the FFA-NIC CO dissolution and then followed by precipitation of the stable form FFA III. Furthermore, a nonlinear relationship of the concentration vs time data acquired for the FFA-NIC CO (01-1) face in Figure 5 (b) also concluded precipitation of FFA solids on the dissolving crystal surface. In contrast, no supersaturation was generated by dissolution of FFA I crystals, confirmed by the PXRD results in Figure 9 (a) where the solid residues collected after the FFA I dissolution tests were the same as the starting materials.
According to the FFA-TP CO structure shown in Figure 2 , an extended chain structure formed by a supramolecular ladder network involving both FFA and TP molecules with a strong hydrogen bond and interactions of C-H···π and π···π implies that the stronger crystal lattice of FFA-TP COs hinders surface dissolution and hence impacts the overall solubility.
However, each surface of a FFA-TP CO becomes more hydrophilic due to inclusion of TP molecules in the crystal lattice in comparison with those of FFA I shown in Figure 2 , leading to an increased interaction force between the faces of FFA-TP COs and aqueous solvent molecules. Therefore, FFA-TP CO has a limited ability to improve the FFA solubility by 2.25 fold in Table 2 . Similarly to the parent drug FFA I, the dissolution mechanism of FFA-TP COs appears to be controlled by defect locations on the crystal surface and the underlying crystal lattice. Because the molecules at defect sites have higher mobility to be detached from the surface, a regular etching pattern can be formed during etching dissolution, which was This would then lead to a smaller local supersaturation of FFA near the dissolving FFA-TP CO surface, thereby explaining the lack of surface precipitation.
When a polymer of PEG, PVP or PVP-VA was pre-dissolved in the dissolution medium, dissolution profiles of FFA-NIC CO or FFA-TP CO changed to significantly different extents under either sink or non-sink conditions. In this study, the used polymer concentration of 200 µg/mL was so low that the solution viscosity remained the same as that of the PBS dissolution medium alone. Furthermore, the pre-dissolved polymer had no effect on the solubility of FFA I [ Table 2 ]. Therefore the effects of polymeric additives on the dissolution of FFA cocrystals are attributed to surface adsorption of the polymers through specific interactions with the crystal surface, in particular, hydrogen bonding. [17] [18] [19] [20] 23, 26, 38, 39 Among the polymers used in this study, PEG, containing a high percentage of hydrogen acceptors in the backbone, is the most hydrophilic, while PVP-VA, containing 40% acetate side chains in comparison to PVP, is the most hydrophobic.
11
Based on the dissolution experiment of the single FFA I crystal, the FFA I (100) face is more hydrophobic because it has a slower face dissolution rate in Figure 5 COs were the only solid phase in Figure 9 (b). Consequently an increased in Table 5 was generated by the FFA-TP CO dissolution.
In the presence of PEG in PBS, the FFA-NIC (01-1) face dissolution rate increased and its (100) face dissolution rate reduced in Figure 5 increasing polymer concentration or new approaches have to be developed to completely inhibit the FFA precipitation, which is part of on-going research in our group.
CONCLUSIONS
Understanding the dissolution mechanisms of pharmaceutical cocrystals can lead to strategies for improving cocrystal design and its optimum product development. In this study, effects of the three polymers, PEG, PVP and PVP-VA, on the dissolution behaviour of the cocrystals of FFA-TP CO and FFA-NIC CO were investigated at multiple length scales. At the molecular level, the interactions of a crystal surface with a polymer by observing etching pattern changes using AFM. At the macroscopic scale, dissolution rates of particular faces of a single crystal were determined by measurement of the physical retreat velocities of the faces using OLM. In the bulk experiments, the FFA concentration in a dissolution medium in the absence or presence of a polymer was measured under both sink and non-sink conditions. It has been found that the dissolution mechanisms of FFA-TP CO are controlled by the defect sites of the crystal surface and by precipitation of the parent drug as individual crystals in the bulk fluid.
In contrast, the dissolution mechanisms of FFA-NIC CO are controlled by the surface layer removal and by a surface precipitation mechanism, where the parent drug precipitates directly onto the surface of the dissolving cocrytals as a coating layer. Through controlling the dissolution environment by pre-dissolving a polymer, PVP or PVP-VA, which can interact with the crystal surface to alter its dissolution properties, the advantages of the improved solubility and dissolution rates of the FFA-TP CO and FFA-NIC CO can be demonstrated.
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